|
| 36824922 | Association of Polygenic Score and the involvement of Cholinergic and Glutamatergic Pathways with Lithium Treatment Response in Patients with Bipolar Disorder. | Res Sq | 2023 |
| 37595325 | Biological markers of sex-based differences in major depressive disorder and in antidepressant response. | Eur Neuropsychopharmacol | 2023 |
| 38077040 | Exploring the genetics of lithium response in bipolar disorders. | Res Sq | 2023 |
| 37886563 | Lithium Response in Bipolar Disorder is Associated with Focal Adhesion and PI3K-Akt Networks: A Multi-omics Replication Study. | Res Sq | 2023 |
| 37643212 | Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by <i>HLA-DRB1*04</i> subtypes. | Proc Natl Acad Sci U S A | 2023 |
| 37972722 | Melatonin MT<sub>1</sub> receptors as a target for the psychopharmacology of bipolar disorder: A translational study. | Pharmacol Res | 2023 |
| 37190658 | Probing the Association between Cognition, Suicidal Behavior and Tryptophan Metabolism in a Sample of Individuals Living with Bipolar Disorder: A Secondary Analysis. | Brain Sci | 2023 |
| 37373213 | RNA Biomarkers in Bipolar Disorder and Response to Mood Stabilizers. | Int J Mol Sci | 2023 |
| 37236419 | A genome-wide association study of antidepressant-induced mania. | Prog Neuropsychopharmacol Biol Psychiatry | 2023 |
| 37433967 | Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder. | Mol Psychiatry | 2023 |
| 37461719 | Immunogenetics of lithium response and psychiatric phenotypes in patients with bipolar disorder. | Res Sq | 2023 |
| 37195665 | Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease. | JAMA Netw Open | 2023 |
| 36902205 | Pharmacokinetic Markers of Clinical Outcomes in Severe Mental Illness: A Systematic Review. | Int J Mol Sci | 2023 |
| 34743061 | Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders. | Eur Neuropsychopharmacol | 2022 |
| 35379992 | New insights into the genetic etiology of Alzheimer's disease and related dementias. | Nat Genet | 2022 |
| 35505515 | Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach - CORRIGENDUM. | Br J Psychiatry | 2022 |
| 35639372 | Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease. | JAMA Neurol | 2022 |
| 35566641 | Is Poor Lithium Response in Individuals with Bipolar Disorder Associated with Increased Degradation of Tryptophan along the Kynurenine Pathway? Results of an Exploratory Study. | J Clin Med | 2022 |
| 35817769 | Correction: Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients. | Transl Psychiatry | 2022 |
| 36552127 | Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders. | Brain Sci | 2022 |
| 36422266 | Investigation of Genetic Variants Associated with Tryptophan Metabolite Levels via Serotonin and Kynurenine Pathways in Patients with Bipolar Disorder. | Metabolites | 2022 |
| 36041245 | Ethical considerations for precision psychiatry: A roadmap for research and clinical practice. | Eur Neuropsychopharmacol | 2022 |
| 36244519 | Lithium: new observations on an old medication. | Neurosci Lett | 2022 |
| 35930170 | Cost-Utility Analysis of Pharmacogenetic Testing Based on CYP2C19 or CYP2D6 in Major Depressive Disorder: Assessing the Drivers of Different Cost-Effectiveness Levels from an Italian Societal Perspective. | Clin Drug Investig | 2022 |
| 36253798 | Analysis on in vitro effect of lithium on telomere length in lymphoblastoid cell lines from bipolar disorder patients with different clinical response to long-term lithium treatment. | Hum Genomics | 2022 |
| 36281033 | Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients. | Eur Psychiatry | 2022 |
| 35163479 | Genetic and Epigenetic Markers of Lithium Response. | Int J Mol Sci | 2022 |
| 35016057 | Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review. | Eur Neuropsychopharmacol | 2022 |
| 35225756 | Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach. | Br J Psychiatry | 2022 |
| 35045295 | A bidirectional competitive interaction between circHomer1 and Homer1b within the orbitofrontal cortex regulates reversal learning. | Cell Rep | 2022 |
| 35238627 | Gut microbiota and treatment-resistant schizophrenia: many questions, fewer answers. | Pharmacogenomics | 2022 |
| 34607722 | Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review. | Eur Neuropsychopharmacol | 2022 |
| 34844152 | A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response. | Eur Neuropsychopharmacol | 2022 |
| 33441847 | Prediction of lithium response using genomic data. | Sci Rep | 2021 |
| 36408127 | Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study. | Complex Psychiatry | 2021 |
| 33673559 | Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review. | Brain Sci | 2021 |
| 35048876 | Characterisation of age and polarity at onset in bipolar disorder. | Br J Psychiatry | 2021 |
| 34893581 | Circular RNA circCCNT2 is upregulated in the anterior cingulate cortex of individuals with bipolar disorder. | Transl Psychiatry | 2021 |
| 34440078 | Involvement of Gut Microbiota in Schizophrenia and Treatment Resistance to Antipsychotics. | Biomedicines | 2021 |
| 34497278 | HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders. | Sci Rep | 2021 |
| 34845190 | Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients. | Transl Psychiatry | 2021 |
| 34035470 | Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions. | Neuropsychopharmacology | 2021 |
| 34196012 | Personalized treatments in neuropsychiatric disorders. | Drug Dev Res | 2021 |
| 34282075 | Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder. | Psychiatr Genet | 2021 |
| 33431852 | Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder. | Transl Psychiatry | 2021 |
| 32425581 | Challenges and Future Prospects of Precision Medicine in Psychiatry. | Pharmgenomics Pers Med | 2020 |
| 31675136 | Leukocyte telomere length is reduced in patients with major depressive disorder. | Drug Dev Res | 2020 |
| 31645113 | Major depression subtypes are differentially associated with migraine subtype, prevalence and severity. | Cephalalgia | 2020 |
| 32054361 | Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals. | Expert Rev Mol Diagn | 2020 |
| 31988227 | A multidisciplinary approach to mental illness: do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders. | BMJ Open | 2020 |